Overall survival in the KEYNOTE-671 study of perioperative pembrolizumab for early-stage non-small-cell lung cancer NSCLC) Spicer, J. D., Gao, S., Liberman, M., Kato, T., Tsuboi, M., Lee, S. H., Chen, K. N., Dooms, C., Majem, M., Eigendorff, E., Martinengo, G., Bylicki, O., Garassino, M. C., Abreu, D., Chaft, J., Novello, S., Yang, J., Keller, S. M., Samkari, A., Wakelee, H. ELSEVIER. 2023: S1297-S1298

View details for DOI 10.1016/j.annonc.2023.10.052

View details for Web of Science ID 001087480203538